PSNCBAM-1

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by CV9933 (talk | contribs) at 20:32, 17 July 2016 (CS1 maint- authors list.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

PSNCBAM-1
Identifiers
  • 1-(4-chlorophenyl)-3-(3-(6-(pyrrolidin-1-yl)pyridin-2-yl)phenyl)urea
CAS Number
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H21ClN4O
Molar mass392.89 g·mol−1
3D model (JSmol)
  • Clc1ccc(NC(=O)Nc2cccc(c2)c3cccc(n3)N4CCCC4)cc1
  • InChI=1S/C22H21ClN4O/c23-17-9-11-18(12-10-17)24-22(28)25-19-6-3-5-16(15-19)20-7-4-8-21(26-20)27-13-1-2-14-27/h3-12,15H,1-2,13-14H2,(H2,24,25,28)
  • Key:HDAYFSFWIPRJSO-UHFFFAOYSA-N

PSNCBAM-1 is a negative allosteric modulator of the cannabinoid CB1 receptor.[1][2]

See also

References

  1. ^ {{cite journal | title=Diarylureas as Allosteric Modulators of the Cannabinoid CB1 Receptor: Structure–Activity Relationship Studies on 1-(4-Chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1) | vauthors=German N, Decker AM, Gilmour BP, Gay EA, Wiley JL, Thomas BF, Zhang Y | journal=Journal of Medicinal Chemistry | date=September 2014 | volume=57 | issue=18 | pages=7758–7769 | doi=10.1021/jm501042u | pmid=25162172 | PMC=4175001}}
  2. ^ Horswill JG, Bali U, Shaaban S, Keily JF, Jeevaratnam P, Babbs AJ, Reynet C, Wong Kai In P (November 2007). "PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats". British Journal of Pharmacology. 152 (5): 805–814. doi:10.1038/sj.bjp.0707347. PMC 2190018. PMID 17592509.